• Opimec portal. Home
  • Opimec portal. General Info
  • Opimec portal. Manual
  • Opimec portal. Site map
  • Opimec portal. Contact
  • Opimec portal. Help
Junta de Andalucía
Events
ical vcal
< May >
Mo Tu We Th Fr Sa Su
30 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 1 2 3
List

References: Prevention and health promotion

Vote
star star star star star ( 4 votes)
  • Imprimir
  • Favorito
last modified: 19/10/2010 11:53

The following are the references that support chapter 3 (back to chapter 3).

Feel free to review them and to suggest improvements by clicking on the green bubble marked 'Comments' that appears on the right top corner of each section. 

 

Table of contents

In order to edit this section in english the portal language needs to be changed to the original document language. After that you can change to your desired language using the language selector
First level chapter Second level chapter Third level chapter Fourth level chapter Fifth level chapter Sixth level chapter
You are editing one or more sections of this document, if you leave this page now any changes you made in the editors will be lost!

Use the "full screen" buttonpantallac to increase the size of the window and you can edit better.

In the upper left, choose the format of the text by selecting from the dropdown menu:

- Paragraph: for normal text

- Chapter of the first level, second or third: to highlight the titles of the sections and build the index. Those statements that highlight in this format will automatically appear in the document index (table of contents).

Use the options Ctrl V or CMD V to paste and CtrlC / CMD C to copy, Ctrl X / CMD X to cut (in some browsers buttons doesn´t work)

Once you finish editing do not forget to save your changes by clicking the bottom left button Save or Cancel if you don´t want to save the changes.

More information here

/media/css/tinybase.css,/media/css/tinycollab.css
Vote
blank blank blank blank blank ( 0 votes)
 

1. Bonita R, Beaglehole R, Kjellstrom T. Basic Epidemiology. 2ªed. Geneva: WHO; 2006.

Vote
blank blank blank blank blank ( 0 votes)
 

2. Research Australia. Healthy planet, places, and people. Canberra: Research Australia; 2007.

Vote
blank blank blank blank blank ( 0 votes)
 

3. Commission on Social Determinants of Health. Closing the gap in a generation: health equity through action on the socail determinants of health. Geneva: WHO; 2008.

Vote
blank blank blank blank blank ( 0 votes)
 

4. WHO. WHO report on the global tobacco epidemic, 2008. The MPOWER package. Geneva: WHO; 2008.

Vote
blank blank blank blank blank ( 0 votes)
 

5. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008; (1): CD000146. DOI: 10.1002/14651858.CD000146.pub3

Vote
blank blank blank blank blank ( 0 votes)
 

6. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG. Use of smoking-cessation treatments in the United States. Am J Prev Med. 2008; 34(2): 102-111.

Vote
blank blank blank blank blank ( 0 votes)
 

7.  Lee CW, Kahende J. Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health. 2007;  97(8): 1503-1509.

Vote
blank blank blank blank blank ( 0 votes)
 

8. Saffer H. Tobacco advertising and promotion. In: Jha P, Chaloupka FI, eds. Tobacco control in developing countries. Oxford: Oxford University Press; 2000.

Vote
blank blank blank blank blank ( 0 votes)
 

9. Van Walbeek C. Tobacco excise in South Africa: tools for advancing tobacco control in the XX1st century: success stories and lessons learned. Geneva: WHO; 2003.

Vote
blank blank blank blank blank ( 0 votes)
 

10.World Health Organisation. Preventing chronic diseases: a vital investment. Geneva: WHO; 2005.

Vote
blank blank blank blank blank ( 0 votes)
 

11. Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane Database Syst Rev. 2006; (4): CD003817. DOI: 10.1002/14651858.CD003817.pub3

Vote
blank blank blank blank blank ( 0 votes)
 

12. Hagobian TA, Braun B. Physical Activity and Hormonal Regulation of Appetite: Sex Differences and Weigth Control. Exerc Sport Sci Rev. 2010; 38(1):25-30.

Vote
blank blank blank blank blank ( 0 votes)
 

13.Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004 Sep; 12(9):1426-34.

Vote
blank blank blank blank blank ( 0 votes)
 

14. Rejeski WJ, Mihalko SL. Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci. (2001); 56(Suppl 2):23-35. DOI:10.1093/gerona/56.suppl_2.23

Vote
blank blank blank blank blank ( 0 votes)
 

15. WHO. Interventions on diet and physical activity: what works. Geneva: WHO; 2009.

Vote
blank blank blank blank blank ( 0 votes)
 

16. Glazier, RH, Booth GL, Gozdyra P, Creatore M, Tynan, A. Neighbourhood environments and resources for health living – a focus on diabetes in Toronto. Toronto: Institute for Clinical Evaluative Sciences; 2007.

Vote
blank blank blank blank blank ( 0 votes)
 

17. WHO. Prevention of cardiovascular disease. Geneva: WHO; 2007.

Vote
blank blank blank blank blank ( 0 votes)
 

18. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007; 335(7611):136.

Vote
blank blank blank blank blank ( 0 votes)
 

19. Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for predicting cardiovascular risk? BMJ. 2009; 339:b2673.

Vote
blank blank blank blank blank ( 0 votes)
 

20. National Institute of Health and Clinical excellence (NICE). MI: secondary prevention. Statins for the prevention of cardiovascular events. London: NICE; 2006.

Vote
blank blank blank blank blank ( 0 votes)
 

21. Pearson TA et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002; 106(3):388-391.

Vote
blank blank blank blank blank ( 0 votes)
 

22. Antithrombotic Triallists Collaboration et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009 May 30; 373(9678):1849-60.

Vote
blank blank blank blank blank ( 0 votes)
 

23. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003; 326(7404): 1419-23.

Vote
blank blank blank blank blank ( 0 votes)
 

24. Indian Polycap Study (TIPS), Yusuf S, Pais P, Afzal R, Xavier D, Teo K, Eikelboom J, Sigamani A, Mohan V, Gupta R, Thomas N. Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial. Lancet. 2009 Apr 18; 373(9672):1341-51.

Vote
blank blank blank blank blank ( 0 votes)
 

25. Mendis S, Abegunde D, Yusuf S, Ebrahim S, Shaper G, Ghannem H, Shengelia B. WHO study on prevention and recurrence of myocardial infraction and stroke (WHO-PREMISE). Bull World Health Organ. 2005; 83(11): 820-8.

Vote
blank blank blank blank blank ( 0 votes)
 

26. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ. 2009;339:b2587. DOI: 10.1136/bmj.b2587

Vote
blank blank blank blank blank ( 0 votes)
 

27. MedicineNet.com. [Web site]. [Access date April 1st, 2010]. Definition of QALY. Available at: http://www.medterms.com/script/main/art.asp?articlekey=7924

Vote
blank blank blank blank blank ( 0 votes)
 

28. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ. 2003; 326(7395): 901. DOI:10.1136/bmj.326.7395.901

Vote
blank blank blank blank blank ( 0 votes)
 

29. Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24):2545-59.

Comments to the whole document Comments feed

no comments yet.
 
Add your comment here

Bellow you have a captcha (a challenge-response test to ensure that you are human). You are required to input the two words displayed in the captcha in order to be able to send the form data.
 
Prevention and health promotion

This is a live interactive document that provides the first collaborative edition for the book chapter on "Prevention and health ...

When people live with multiple chronic diseases: a collaborative approach to an emerging global challenge

This is a live interactive document that seeks to facilitate a global collaborative effort to distill the best available knowledge ...